🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

UHS stock upgraded by Cantor Fitzgerald with bullish acute care forecast

EditorEmilio Ghigini
Published 07/26/2024, 04:50 AM
UHS
-

On Friday, Cantor Fitzgerald adjusted its stance on Universal Health Services (NYSE:UHS), raising the stock from Underweight to Neutral. Accompanying this upgrade, the firm also increased its price target for the healthcare provider to $219.00, up from the previous target of $162.00.

The revision in rating and target price reflects a new assessment of the company's prospects. The analyst from Cantor Fitzgerald indicated a shift in perspective, suggesting that the negative aspects had previously been too heavily factored into Universal Health's valuation.

The firm is now more optimistic about the company's acute care segment and has updated its financial estimates for the years 2024, 2025, and initiated a positive outlook for 2026.

Despite the upgrade, the firm maintains a stance of neutrality towards Universal Health Services' stock. While acknowledging strategies that could lead to margin improvements, concerns remain about the potential for an intensifying labor shortage in the psychiatric field. This is due to wage disparities compared to acute care and the impact of the retirement cycle on staffing.

The analyst's commentary highlighted a re-evaluation of the company's timeline, considering that the benefits in the acute care sector might materialize before the challenges in inpatient psychiatric services become more pressing. This re-evaluation has led to the current neutral position and the updated price target for Universal Health Services.

In other recent news, Universal Health Services has been the focus of several analyst adjustments. Baird upgraded the company's shares from Neutral to Outperform, raising its price target to $236 from $198. This upgrade is based on Baird's belief in the company's potential for significant earnings growth.

Similarly, UBS also upgraded Universal Health Services' stock from Neutral to Buy, raising the price target to $226 from $189, reflecting optimism about the company's earnings potential, particularly in its behavioral health services.

On the dividend front, Universal Health Services declared a cash dividend of $0.20 per share, scheduled for disbursement in June. This dividend announcement is a clear demonstration of the company's ongoing commitment to delivering value to its shareholders.

In addition, RBC Capital and TD Cowen adjusted their price targets for Universal Health Services. RBC Capital raised the price target to $189.00 from $183.00, maintaining a Sector Perform rating, while TD Cowen increased the target to $183 from $181, keeping a Hold rating on the stock. These adjustments are in response to Universal Health Services' strong performance in the first quarter of 2024.

These recent developments reflect a positive outlook on Universal Health Services' financial performance and potential for continued growth. As always, investors are advised to carefully consider these updates and conduct their own research before making investment decisions.

InvestingPro Insights

Following Cantor Fitzgerald's recent upgrade and price target increase for Universal Health Services (NYSE:UHS), it's worth noting some key metrics and insights from InvestingPro that could further inform investors. Universal Health Services boasts a robust Piotroski Score of 9, indicating strong financial health, and management has been actively repurchasing shares, a sign of confidence in the company's value. Additionally, 5 analysts have revised their earnings upwards for the upcoming period, reflecting a positive sentiment towards the company's financial prospects.

InvestingPro Data shows a market capitalization of $13.72B and a P/E Ratio of 14.96, which is attractive when paired with near-term earnings growth. The company's revenue growth over the last twelve months as of Q2 2024 stands at 8.83%, demonstrating a solid performance in its sector. Moreover, with a PEG Ratio of 0.67, Universal Health Services appears to offer growth at a reasonable price.

Investors looking to delve deeper into Universal Health Services' performance and potential can explore additional InvestingPro Tips at https://www.investing.com/pro/UHS. There are many more tips available, including insights into the stock's volatility, industry positioning, and dividend consistency. For those interested in a comprehensive analysis, use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, unlocking access to exclusive insights and data.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.